Join us in Vienna for a comprehensive exploration of translational heart failure research. This prestigious event brings together researchers, clinicians, and industry leaders to discuss the latest advancements in understanding and treating heart failure. Key topics include novel therapeutic targets, patient care innovations, and interdisciplinary collaborations. Our team will share insights from our latest research and engage in discussions on overcoming challenges in heart failure management. Schedule a meeting with us to exchange ideas and explore collaborative opportunities.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
